A 3-month Cycle of Virtual Guided Tours to Promote Health in Older Community Members in a Context of COVID-19 Induced Social Isolation: a Pilot Study
Launched by JEWISH GENERAL HOSPITAL · Oct 13, 2020
Trial Information
Current as of May 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being 65 years and over
- • Having an Internet access and an electronic device (smartphone and/or tablet) at the participant's place of living as the repetitive assessments for this study will be performed on the web platform of the Centre of Excellence on Longevity of McGill University, and the guided tours will be virtual.
- • Understanding and writing the language of the recruitment centre (i.e., French or English)
- Exclusion Criteria:
- • a concomitant participation to an experimental study,
- • planning to have a journey over one week during the cycle of visits,
- • having participated to a participatory art-based activity of the MMFA during the 6 month-period before the recruitment,
- • not speaking the language of the study.
About Jewish General Hospital
The Jewish General Hospital (JGH) is a leading academic health care institution in Montreal, Canada, renowned for its commitment to excellence in patient care, research, and education. As a sponsor of clinical trials, JGH leverages its state-of-the-art facilities and multidisciplinary expertise to advance medical knowledge and improve treatment outcomes across various specialties. The hospital is dedicated to fostering innovation through rigorous scientific investigation and collaboration with renowned research institutions, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements. With a focus on patient-centered research, JGH aims to translate findings into effective therapeutic strategies that enhance the quality of care for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montréal, Quebec, Canada
Patients applied
Trial Officials
Olivier Beauchet, MD
Principal Investigator
Jewish General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials